Healthnational✓ verified · 95%
Drug recall: Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose kits containing: 8-mL vial of 30 mg strength, a pre-filled syringe containing 2 mL of diluent, one vial adapter, and one sterile 1¿ 19-gauge safety injection needle, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 69300 Greece, Manufactured For: TEVA Pharmaceuticals, Parsippany, NJ 07054. NDC Kit Carton: 0480-9262-08; Vial Label: 0480-9260-01; Tray Label: 0480-9262-08; Diluent Label: 0480-9263-21. — Teva Pharmaceuticals USA, Inc
- When
- · day precision
- Where
- Parsippany, NJ, US
- Category
- recall · drug_recall
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Involved actors & entities
People, organizations and places machine-extracted from the source reporting — they power search and the correlation graph. Extracted automatically, so they can include noise, especially on events still marked unverified.
Sources
Defaxon links out to the original reporting and never republishes article text.
Correlated events
Computed by the Defaxon correlation engine — linked by shared actors, co-location, and temporal proximity. Scored hypotheses, never causal claims.
No correlated events found in the current window. As more events arrive, connections form automatically.